Laure Morimont, PharmD phD

University of Namur, Department of Pharmacy, Namur,Belgium
Namur, Namur, Belgium

Laure Morimont, phD, Pharm D, QUALIblood (Namur, Belgium), University of Namur, Department of Pharmacy, Clinical Pharmacology Research Group, Namur Research Institute for Life Sciences (NARILIS) (Namur, Belgium).

After being graduated in pharmaceutical sciences in 2018, Laure Morimont started her PhD in biomedical and pharmaceutical sciences at the University of Namur, Belgium. In 2019, she joined the “PhD in enterprise program” at QUALIblood s.a, a Belgium CRO based in Namur. Her thesis, defended in June 2023, consisted of bringing into clinical routine a test capable of assessing the prothrombotic risk in women using a hormonal therapy. She is now an expert in the field of hormone-induced coagulopathy in women.

Presentation(s):

• OC 35.3 - Correlation between ETP-based APC Resistance and the Relative Risk of Venous Thromboembolism in Women Using Combined Oral Contraceptives

  Monday, June 26, 2023
  11:15 – 11:30 ET

• PB1502 - Hemostatic imbalance associated with tamoxifen in estrogen receptor-positive breast cancer patients: an observational study

  Tuesday, June 27, 2023
  18:30 – 19:30 ET